DFDA

Antiplatelet Therapy (e.g., Aspirin)

Treatment for Vascular Intestinal Disorders

Typical Dosage: Aspirin 81mg daily

Effectiveness
65%
Safety Score
80%
Clinical Trials
1,000
Participants
100K

Comparative Safety Scale(Higher is safer)

Cyanide☠ī¸
Meth💀
CigarettesđŸšŦ
Chemoâ˜ĸī¸
AlcoholđŸē
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
80
DangerousModerateSafe
Treatment Details
Dosage Range
Aspirin 81mg daily
Time to Effect
Days
Treatment Duration
Lifetime
Evidence Quality
HIGH
Number Needed to Treat (NNT)
75(Treat 75 patients to see 1 additional successful outcome)
Number Needed to Harm (NNH)
300(Treat 300 patients to see 1 additional serious adverse event)
Confidence Score
85%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$50
Monitoring:$50
Side Effect Mgmt:$100
Total Annual:$200
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENT
ICER
$15,000/QALY
QALYs Gained
0.2
Comparison vs No treatment
Cost Difference
$-200/year
Less expensive
QALY Difference
+0.20 QALYs
Better outcomes
Dominance
DOMINATESBetter + cheaper
Antiplatelet Therapy (e.g., Aspirin) Outcomes

for Vascular Intestinal Disorders

Efficacy Outcomes
Overall Effectiveness
+65%
Common Side Effects
GI upset
+10%
Bleeding (GI)
+2%

Sources:

nih.gov
nih.gov
researchgate.net

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
1 active trial recruiting for Antiplatelet Therapy (e.g., Aspirin) in Vascular Intestinal Disorders

Effects of Rosa Roxburghii Tratt Freeze-Dried Powder on Carotid Atherosclerotic Plaques: A Real-World Study

NCT07840950NOT YET RECRUITINGNA
View Study
200 participants
INTERVENTIONAL
Started: Sep 1, 2026